Ball, A.J. and Tettey, J.N.A. and Grant, M.H. (2004) The toxicity of troglitazone, roziglitazone and vitamin e in human hep g2 hepatoma cells. Toxicology, 194 (3). pp. 250-251. ISSN 0300-483X
Full text not available in this repository. (Request a copy from the Strathclyde author)Official URL: http://dx.doi.org/10.1016/j.tox.2003.09.003
Abstract
Troglitazone (TGZ), a member of the thiazolidinedione class of drugs used to treat type-II diabetes, has been associated with hepatotoxicity (Biswas et al., 2001). TGZ differs structurally from the newer non-hepatotoxic glitazone, rosiglitazone (RGZ), in that it contains the chromanol moiety of Vitamin E (Vit E). This study compares the toxicity of TGZ, RGZ and Vit E in human HepG2 cells
| Item type: | Article |
|---|---|
| ID code: | 37819 |
| Notes: | Abstracts of the British Toxicology Society Annual Congress 2003. |
| Keywords: | troglitazone, roziglitazone, toxiciology, Pharmacy and materia medica |
| Subjects: | Medicine > Pharmacy and materia medica |
| Department: | Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Faculty of Engineering > Bioengineering |
| Related URLs: | |
| Depositing user: | Pure Administrator |
| Date Deposited: | 22 Feb 2012 15:41 |
| Last modified: | 12 Mar 2012 11:48 |
| URI: | http://strathprints.strath.ac.uk/id/eprint/37819 |
Actions (login required)
| View Item |